Shuang Wen Zhang
Director/Board Member bij Xiamen LP Pharmaceutical Co., Ltd.
Profiel
Shuang Wen Zhang is a Member-Supervisory Board at Xiamen LP Pharmaceutical Co., Ltd.
since 2020.
Previously, Zhang held the same position at Shenzhen Bioeasy Biotechnology Co. Ltd.
Zhang earned a doctorate degree from Xiamen University in 2005.
Actieve functies van Shuang Wen Zhang
Bedrijven | Functie | Begin |
---|---|---|
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Director/Board Member | 13-11-2020 |
Eerdere bekende functies van Shuang Wen Zhang
Bedrijven | Functie | Einde |
---|---|---|
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. | Director/Board Member | - |
Opleiding van Shuang Wen Zhang
Xiamen University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Commercial Services |